IDEAYA Biosciences, Inc (NASDAQ:IDYA) Accelerates Registrational Push With 2026 Data Catalysts
![]() |
IDEAYA enters a catalyst-rich window as clinical program sequencing and strong cash metrics support near-term development execution. Operational profitability metrics contrast with short-term technical pressure, producing a clear fundamental/technical duality. |










